期刊文献+

Tju103和CTLA4-Ig诱导MHC半相合小鼠骨髓移植耐受比较 被引量:2

Comparison of Tju103 and CTLA4-Ig in Induction of Tolerance in MHC Haploidentical Bone Marrow Transplantation in Mice
下载PDF
导出
摘要 目的:观察Tju103和CTLA4-Ig各自对MHC半相合小鼠骨髓移植免疫耐受的诱导。方法:半相合供鼠T细胞与受鼠抗原、Tju103(或CTLA4-Ig)共育后与骨髓细胞混合移植,观测移植后受情况。结果:A.单纯照射组:全部小鼠于照射后11d内死于造血衰竭;B.白血病CTX治疗组:全部小鼠于接种白血病细胞后16~23d死于白血病;C.单纯移植组:全部小鼠于移植后21d内死于移植物抗宿主病(GVHD);D.CsA预防组:5只小鼠于移植后8~22d死亡,1只死于白血病,各有2只死于GVHD和感染,5只活过30d;E.Tju103处理组:4只小鼠于移植后9~26d死亡,2只死于GVHD,各有1只死于白血病和感染,6只活过30d;F.CTLA4-Ig处理组:2只小鼠于移植后17~26d死亡GVHD,8只活过30d。结论:Tju103和CT-LA4-Ig均明显延长生存期,降低GVHD发生和严重程度,CTLA4-Ig保留有抗感染和移植抗白血病(GVL)作用,而Tju103没有。 Objective: To observe the respective effects of Tju103 and CTLA4-Ig on tolerance, post haploidentical mice bone marrow transplantation. Methods:In the presence of the recipient antigen, T cells from the haploidentical do- nors were first cultured with Tju103 or CTLA4-Ig, then mixed with the bone marrow cells and transfused into the recipi- ents. At last, they were observed on the effect on tolerance post transplantation. Results: A. The only irradiated group: All the mice died of failure of hematopoiesis within 11 days post irradiation. B. The CTX-treated leukemia group: All the mice died of leukemia within 16-23 days. C. The only transplanted group: All cases died of GVHD within 21 days post transplantation. D. The CsA prophylaxis group: 5 mice died within 8-22 days after transplantation, of which one died of leukemia, and two died of GVHD and infection respectively leaving 5 survived over 30 days post transplantation. E. The Tju103 treated group: 4 mice died within 9-26 days post transplantation, of which one died of leukemia and infection re- spectively, and two died of GVHD leaving 6 mice survived over 30 days post transplantation. F. The CTLA4-Ig treated group: 2 mice died of GVHD within 17~26 days after transplantation leaving 8 survived over 30 days post transplantation. Conclusions:Tju103 or CTLA4-Ig could alone improve survival time and reduce incidence and degree of GVHD respec- tively. But CTLA4-Ig could preserve ability of GVL effect and anti-infection potential while Tju103 couldn't.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 2003年第4期248-252,共5页 Chinese Journal of Cancer Biotherapy
基金 军队医学科学基金十五重点课题项目(01Z050)
关键词 半相合骨髓移植 免疫耐受 CTLA4—Ig TJU103 抗宿主病 移植物 抗白血病 haploidentical bone marrow transplantation tolerance CTLA4-Ig Tju103 GVHD GVL
  • 相关文献

参考文献2

二级参考文献5

  • 1Slavin S,Nagler A,Naparstek E,et al.Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.Blood,1998; 91:756 -763
  • 2Grimm J,Zeller W Zander AR,et al.Soluble interleukin-2 recetor serum levers after allogeneic bone marrow transplantation as a marker for GVHD.Bone Marrow Transplant,1998;21:29 -32
  • 3Holler E,Roncarolo MG,Hintermeler-Knabe R,et al.Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation.Bone Marrow Transplant,2000;25:237 -241
  • 4Ferrara JL,Krenger W.Graft-versus-host disease:the influence of type 1 and type2 T cell cytokines.Transfus Med Rev,1998; 12:1-7
  • 5Murphy WJ,Welniak LA,Taub DD,et al.Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.J Clin Invest,1998; 102:1742-1748

同被引文献12

  • 1刘峰,楼国良,李永梅,陈莉,黄正霞,杨宏斌,朱杨,王梁华,球谊,焦炳华.选择性去除骨髓移植物中异基因反应性淋巴细胞[J].中国肿瘤生物治疗杂志,2004,11(2):110-113. 被引量:3
  • 2Goker H, Haznedaroglu IC, Chao NJ. Acute graft-vu-host disease: Pathobiology and magnagement [J]. Exp Hematol,2001, 29: 259-277.
  • 3Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietictransplants [J]. Science, 2002, 15. 295(5562): 2097-2100.
  • 4Suss G, Shortman K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis[J]. J Exp Med, 1996, 183(4): 1789-1796.
  • 5Inaba K, Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor[J]. J Exp Med, 1992, 176(6): 1693-1702.
  • 6Kim YM, Sachs T, Asavaroengchai W, et al. Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720[J]. J Clin Invest, 2003, 111(5): 659-669.
  • 7VanPL, Ibraghimov A, Abbas AK. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance[J]. Immunity, 1996, 4(3): 321-328.
  • 8Lenardo M, Chan KM, Hornung F, et al. Mature T lymphocyte apoptosis immune regulation in a dynamic and unpredictable antigenic environment[J]. Annu Rev Immunol, 1999, 17: 221-253.
  • 9Steinman RM. The dendritic cell system and its role in immunogenicity[J]. Annu Rev Immunol, 1991, 9: 271-296.
  • 10Shlomchik WD, Couzens MS, Tang CB, et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells[J]. Science, 1999, 285(5426): 412-415.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部